Loading…
Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head
Background and purpose It has been suggested that avascular osteonecrosis (AVN) of the femoral head develops early after renal transplantation. We evaluated the relationship between risk of AVN and dose of steroids administered in different time periods. Methods Development of AVN was determined u...
Saved in:
Published in: | Acta orthopaedica 2008-01, Vol.79 (5), p.631-636 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3 |
container_end_page | 636 |
container_issue | 5 |
container_start_page | 631 |
container_title | Acta orthopaedica |
container_volume | 79 |
creator | Shibatani, Masahiko Fujioka, Mikihiro Arai, Yuji Takahashi, Kenji Ueshima, Keiichiro Okamoto, Masahiko Yoshimura, Norio Hirota, Yoshio Fukushima, Wakaba Kubo, Toshikazu |
description | Background and purpose It has been suggested that avascular osteonecrosis (AVN) of the femoral head develops early after renal transplantation. We evaluated the relationship between risk of AVN and dose of steroids administered in different time periods.
Methods Development of AVN was determined using MRI at 3-6 weeks, 9-12 weeks, 24 weeks, and 12 months after transplantation in 150 patients (96 males). We investigated possible associations between acute rejection reactions, the dose of cyclosporine, tacrolimus use, total steroid dose by the second, fourth, sixth, or eighth weeks after transplantation, and incidence of AVN.
Results There was no statistically significant difference between incidence of AVN and presence or absence of an acute rejection reaction. We found a statistically significant association between AVN incidence and the total dose of steroids administered during the first 2 months after transplantation, and there was a doseresponse relationship. No other statistically significant associations were found.
Interpretation Our findings confirm that the total dose of steroids given within the first 2 months after renal transplantation has a great influence on the incidence of AVN. |
doi_str_mv | 10.1080/17453670810016641 |
format | article |
fullrecord | <record><control><sourceid>informahealthcare_pubme</sourceid><recordid>TN_cdi_pubmed_primary_18839369</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1080_17453670810016641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EoqXwAGyQNywH_JM4iWCDyl-lSmzadXTHuW5cJfbo2qOqr8OT4kyGIlSpK1tX3znn-pixt1J8kKIVH2VT1do0opVCSGMq-YydLrONNq16_nBvqhP2KqVbIXRbdeIlO5FtqzttulP2-yveECKPjttI2duYMlL0A8-EkGcMmd_5PPrA84jceUqZKz7HkMe0qAgDTAWGkHYThAzZx8BHSBx4yhTDDffBTXsMtqSsLj5YP6wDx5fAGNBSTP7geMjBOVLxHRGG1-yFgynhm-N5xq6_f7s6_7m5_PXj4vzL5cbWSudN3SknBqUaAZ2zg2yx3mLlQBtQzkgjmm3d6K1WTjb20JxUYAVIUxeyc_qMydV3WSURun5Hfga676Xol777R30XzbtVs9tvZxz-KY4FF-D9EYBkYXKlJ-vTA6dEU2lTLdznlStlRZrhLtI09Bnup0h_RfqpPT79Jy-9TXm0QNjfxj2VL0pPvOIPfR-wlA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head</title><source>EBSCOhost SPORTDiscus with Full Text</source><creator>Shibatani, Masahiko ; Fujioka, Mikihiro ; Arai, Yuji ; Takahashi, Kenji ; Ueshima, Keiichiro ; Okamoto, Masahiko ; Yoshimura, Norio ; Hirota, Yoshio ; Fukushima, Wakaba ; Kubo, Toshikazu</creator><creatorcontrib>Shibatani, Masahiko ; Fujioka, Mikihiro ; Arai, Yuji ; Takahashi, Kenji ; Ueshima, Keiichiro ; Okamoto, Masahiko ; Yoshimura, Norio ; Hirota, Yoshio ; Fukushima, Wakaba ; Kubo, Toshikazu</creatorcontrib><description>Background and purpose It has been suggested that avascular osteonecrosis (AVN) of the femoral head develops early after renal transplantation. We evaluated the relationship between risk of AVN and dose of steroids administered in different time periods.
Methods Development of AVN was determined using MRI at 3-6 weeks, 9-12 weeks, 24 weeks, and 12 months after transplantation in 150 patients (96 males). We investigated possible associations between acute rejection reactions, the dose of cyclosporine, tacrolimus use, total steroid dose by the second, fourth, sixth, or eighth weeks after transplantation, and incidence of AVN.
Results There was no statistically significant difference between incidence of AVN and presence or absence of an acute rejection reaction. We found a statistically significant association between AVN incidence and the total dose of steroids administered during the first 2 months after transplantation, and there was a doseresponse relationship. No other statistically significant associations were found.
Interpretation Our findings confirm that the total dose of steroids given within the first 2 months after renal transplantation has a great influence on the incidence of AVN.</description><identifier>ISSN: 1745-3674</identifier><identifier>EISSN: 1745-3682</identifier><identifier>DOI: 10.1080/17453670810016641</identifier><identifier>PMID: 18839369</identifier><language>eng</language><publisher>Basingstoke: Informa UK Ltd</publisher><subject><![CDATA[Adolescent ; Adult ; Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; Cyclosporine - administration & dosage ; Cyclosporine - adverse effects ; Diseases of the osteoarticular system ; Dose-Response Relationship, Drug ; Female ; Femur Head Necrosis - chemically induced ; Femur Head Necrosis - etiology ; Glucocorticoids - administration & dosage ; Glucocorticoids - adverse effects ; Graft Rejection ; Humans ; Immunosuppressive Agents - administration & dosage ; Immunosuppressive Agents - adverse effects ; Kidney Transplantation - adverse effects ; Male ; Medical sciences ; Methylprednisolone - administration & dosage ; Methylprednisolone - adverse effects ; Pharmacology. Drug treatments ; Postoperative Complications - chemically induced ; Postoperative Complications - etiology ; Prednisolone - administration & dosage ; Prednisolone - adverse effects ; Risk Factors ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Tacrolimus - administration & dosage ; Tacrolimus - adverse effects ; Time Factors ; Vascular bone diseases]]></subject><ispartof>Acta orthopaedica, 2008-01, Vol.79 (5), p.631-636</ispartof><rights>2008 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2008</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3</citedby><cites>FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20743649$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18839369$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shibatani, Masahiko</creatorcontrib><creatorcontrib>Fujioka, Mikihiro</creatorcontrib><creatorcontrib>Arai, Yuji</creatorcontrib><creatorcontrib>Takahashi, Kenji</creatorcontrib><creatorcontrib>Ueshima, Keiichiro</creatorcontrib><creatorcontrib>Okamoto, Masahiko</creatorcontrib><creatorcontrib>Yoshimura, Norio</creatorcontrib><creatorcontrib>Hirota, Yoshio</creatorcontrib><creatorcontrib>Fukushima, Wakaba</creatorcontrib><creatorcontrib>Kubo, Toshikazu</creatorcontrib><title>Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head</title><title>Acta orthopaedica</title><addtitle>Acta Orthop</addtitle><description>Background and purpose It has been suggested that avascular osteonecrosis (AVN) of the femoral head develops early after renal transplantation. We evaluated the relationship between risk of AVN and dose of steroids administered in different time periods.
Methods Development of AVN was determined using MRI at 3-6 weeks, 9-12 weeks, 24 weeks, and 12 months after transplantation in 150 patients (96 males). We investigated possible associations between acute rejection reactions, the dose of cyclosporine, tacrolimus use, total steroid dose by the second, fourth, sixth, or eighth weeks after transplantation, and incidence of AVN.
Results There was no statistically significant difference between incidence of AVN and presence or absence of an acute rejection reaction. We found a statistically significant association between AVN incidence and the total dose of steroids administered during the first 2 months after transplantation, and there was a doseresponse relationship. No other statistically significant associations were found.
Interpretation Our findings confirm that the total dose of steroids given within the first 2 months after renal transplantation has a great influence on the incidence of AVN.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Cyclosporine - administration & dosage</subject><subject>Cyclosporine - adverse effects</subject><subject>Diseases of the osteoarticular system</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Femur Head Necrosis - chemically induced</subject><subject>Femur Head Necrosis - etiology</subject><subject>Glucocorticoids - administration & dosage</subject><subject>Glucocorticoids - adverse effects</subject><subject>Graft Rejection</subject><subject>Humans</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methylprednisolone - administration & dosage</subject><subject>Methylprednisolone - adverse effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Postoperative Complications - chemically induced</subject><subject>Postoperative Complications - etiology</subject><subject>Prednisolone - administration & dosage</subject><subject>Prednisolone - adverse effects</subject><subject>Risk Factors</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Tacrolimus - administration & dosage</subject><subject>Tacrolimus - adverse effects</subject><subject>Time Factors</subject><subject>Vascular bone diseases</subject><issn>1745-3674</issn><issn>1745-3682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhS0EoqXwAGyQNywH_JM4iWCDyl-lSmzadXTHuW5cJfbo2qOqr8OT4kyGIlSpK1tX3znn-pixt1J8kKIVH2VT1do0opVCSGMq-YydLrONNq16_nBvqhP2KqVbIXRbdeIlO5FtqzttulP2-yveECKPjttI2duYMlL0A8-EkGcMmd_5PPrA84jceUqZKz7HkMe0qAgDTAWGkHYThAzZx8BHSBx4yhTDDffBTXsMtqSsLj5YP6wDx5fAGNBSTP7geMjBOVLxHRGG1-yFgynhm-N5xq6_f7s6_7m5_PXj4vzL5cbWSudN3SknBqUaAZ2zg2yx3mLlQBtQzkgjmm3d6K1WTjb20JxUYAVIUxeyc_qMydV3WSURun5Hfga676Xol777R30XzbtVs9tvZxz-KY4FF-D9EYBkYXKlJ-vTA6dEU2lTLdznlStlRZrhLtI09Bnup0h_RfqpPT79Jy-9TXm0QNjfxj2VL0pPvOIPfR-wlA</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Shibatani, Masahiko</creator><creator>Fujioka, Mikihiro</creator><creator>Arai, Yuji</creator><creator>Takahashi, Kenji</creator><creator>Ueshima, Keiichiro</creator><creator>Okamoto, Masahiko</creator><creator>Yoshimura, Norio</creator><creator>Hirota, Yoshio</creator><creator>Fukushima, Wakaba</creator><creator>Kubo, Toshikazu</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20080101</creationdate><title>Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head</title><author>Shibatani, Masahiko ; Fujioka, Mikihiro ; Arai, Yuji ; Takahashi, Kenji ; Ueshima, Keiichiro ; Okamoto, Masahiko ; Yoshimura, Norio ; Hirota, Yoshio ; Fukushima, Wakaba ; Kubo, Toshikazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Cyclosporine - administration & dosage</topic><topic>Cyclosporine - adverse effects</topic><topic>Diseases of the osteoarticular system</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Femur Head Necrosis - chemically induced</topic><topic>Femur Head Necrosis - etiology</topic><topic>Glucocorticoids - administration & dosage</topic><topic>Glucocorticoids - adverse effects</topic><topic>Graft Rejection</topic><topic>Humans</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methylprednisolone - administration & dosage</topic><topic>Methylprednisolone - adverse effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Postoperative Complications - chemically induced</topic><topic>Postoperative Complications - etiology</topic><topic>Prednisolone - administration & dosage</topic><topic>Prednisolone - adverse effects</topic><topic>Risk Factors</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Tacrolimus - administration & dosage</topic><topic>Tacrolimus - adverse effects</topic><topic>Time Factors</topic><topic>Vascular bone diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shibatani, Masahiko</creatorcontrib><creatorcontrib>Fujioka, Mikihiro</creatorcontrib><creatorcontrib>Arai, Yuji</creatorcontrib><creatorcontrib>Takahashi, Kenji</creatorcontrib><creatorcontrib>Ueshima, Keiichiro</creatorcontrib><creatorcontrib>Okamoto, Masahiko</creatorcontrib><creatorcontrib>Yoshimura, Norio</creatorcontrib><creatorcontrib>Hirota, Yoshio</creatorcontrib><creatorcontrib>Fukushima, Wakaba</creatorcontrib><creatorcontrib>Kubo, Toshikazu</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Acta orthopaedica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shibatani, Masahiko</au><au>Fujioka, Mikihiro</au><au>Arai, Yuji</au><au>Takahashi, Kenji</au><au>Ueshima, Keiichiro</au><au>Okamoto, Masahiko</au><au>Yoshimura, Norio</au><au>Hirota, Yoshio</au><au>Fukushima, Wakaba</au><au>Kubo, Toshikazu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head</atitle><jtitle>Acta orthopaedica</jtitle><addtitle>Acta Orthop</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>79</volume><issue>5</issue><spage>631</spage><epage>636</epage><pages>631-636</pages><issn>1745-3674</issn><eissn>1745-3682</eissn><abstract>Background and purpose It has been suggested that avascular osteonecrosis (AVN) of the femoral head develops early after renal transplantation. We evaluated the relationship between risk of AVN and dose of steroids administered in different time periods.
Methods Development of AVN was determined using MRI at 3-6 weeks, 9-12 weeks, 24 weeks, and 12 months after transplantation in 150 patients (96 males). We investigated possible associations between acute rejection reactions, the dose of cyclosporine, tacrolimus use, total steroid dose by the second, fourth, sixth, or eighth weeks after transplantation, and incidence of AVN.
Results There was no statistically significant difference between incidence of AVN and presence or absence of an acute rejection reaction. We found a statistically significant association between AVN incidence and the total dose of steroids administered during the first 2 months after transplantation, and there was a doseresponse relationship. No other statistically significant associations were found.
Interpretation Our findings confirm that the total dose of steroids given within the first 2 months after renal transplantation has a great influence on the incidence of AVN.</abstract><cop>Basingstoke</cop><pub>Informa UK Ltd</pub><pmid>18839369</pmid><doi>10.1080/17453670810016641</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1745-3674 |
ispartof | Acta orthopaedica, 2008-01, Vol.79 (5), p.631-636 |
issn | 1745-3674 1745-3682 |
language | eng |
recordid | cdi_pubmed_primary_18839369 |
source | EBSCOhost SPORTDiscus with Full Text |
subjects | Adolescent Adult Biological and medical sciences Bones, joints and connective tissue. Antiinflammatory agents Cyclosporine - administration & dosage Cyclosporine - adverse effects Diseases of the osteoarticular system Dose-Response Relationship, Drug Female Femur Head Necrosis - chemically induced Femur Head Necrosis - etiology Glucocorticoids - administration & dosage Glucocorticoids - adverse effects Graft Rejection Humans Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - adverse effects Kidney Transplantation - adverse effects Male Medical sciences Methylprednisolone - administration & dosage Methylprednisolone - adverse effects Pharmacology. Drug treatments Postoperative Complications - chemically induced Postoperative Complications - etiology Prednisolone - administration & dosage Prednisolone - adverse effects Risk Factors Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the urinary system Tacrolimus - administration & dosage Tacrolimus - adverse effects Time Factors Vascular bone diseases |
title | Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T22%3A35%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Degree%20of%20corticosteroid%20treatment%20within%20the%20first%202%20months%20of%20renal%20transplantation%20has%20a%20strong%20influence%20on%20the%20incidence%20of%20osteonecrosis%20of%20the%20femoral%20head&rft.jtitle=Acta%20orthopaedica&rft.au=Shibatani,%20Masahiko&rft.date=2008-01-01&rft.volume=79&rft.issue=5&rft.spage=631&rft.epage=636&rft.pages=631-636&rft.issn=1745-3674&rft.eissn=1745-3682&rft_id=info:doi/10.1080/17453670810016641&rft_dat=%3Cinformahealthcare_pubme%3E10_1080_17453670810016641%3C/informahealthcare_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c523t-592f0d2270a9fcd18e5be4fa36a2f61607b573b32f17c1745312ac0a165e5b9f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/18839369&rfr_iscdi=true |